Research Article
Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis
Table 1
General information of nephrolithiasis patients with SIRS and non-SIRS.
| Characteristics | SIRS group | Non-SIRS group | Total |
| Number of cases () | 39 | 25 | 64 | Gender (M/F) | 24/15 | 16/9 | 40/24 | Mean age (years) (mean ± SD) | 39.2 ± 9.7 | 34.9 ± 7.1# | 36.7 ± 8.2 | Stone size (length × width × height/mm) | 20 ± 4 × 8 ± 2 × 10 ± 6 | 15 ± 6 × 9 ± 3 × 8 ± 2 | / | Body temperature (°C) | 38.5 ± 0.6 | 36.8 ± 0.3* | / | Blood WBC (×109/L) | 12.9 ± 2.3 | 6 ± 1.2* | / | Bacteria culture positive (/%) | 8 (20.5%) | 0* | / | Blood urea nitrogen (mmol/L) (mean ± SD) | 7.1 ± 1.7 | 5.4 ± 1.2* | / | Serum creatinine (μmol/L) (mean ± SD) | 84.19 ± 7.55 | 67.63 ± 10.43* | / | Urinary WBC (/hp) (mean ± SD) | 30 ± 13 | 4 ± 3* | / | Length of stay in hospital (days) (mean ± SD) | 16.5 ± 7.1 | 9.4 ± 8.4* | / |
|
|
; SIRS group versus non-SIRS group. ; SIRS group versus non-SIRS group. Standard BUN 1.8–7.1 mmol/L; standard SCr 59–104 mmol/L.
|